Legend Star logo

Legend Star

Asia, Beijing, China, Beijing

Description

Legend Star Specializes in early stage investments in technologies transforming traditional industries.

Investor Profile

Legend Star has made 31 investments, with 6 in the past 12 months and 13% as lead.

Stage Focus

  • Seed (39%)
  • Series A (35%)
  • Series Unknown (6%)
  • Series B (6%)
  • Angel (6%)
  • Series D (3%)
  • Series C (3%)

Country Focus

  • United States (52%)
  • China (35%)
  • France (6%)
  • Taiwan (3%)
  • Hong Kong (3%)

Industry Focus

  • Software
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Information Technology
  • Machine Learning
  • Saas
  • Robotics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Legend Star frequently co-invest with?

Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
F50
North America, California, United States, Palo Alto
Co-Investments: 2
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
CL
North America, California, United States, San Francisco
Co-Investments: 8
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Polychain
North America, California, United States, San Francisco
Co-Investments: 3
Lux Capital
North America, New York, United States, New York
Co-Investments: 3
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 2

Which angels does Legend Star often collaborate with?

WG
North America, California, United States, San Francisco
Shared Deals: 1
JK
North America, California, United States, Redwood City
Shared Deals: 1
SD
North America, California, United States, Los Angeles
Shared Deals: 1
EK
North America, California, United States, San Francisco
Shared Deals: 1
AP
North America, California, United States, San Francisco
Shared Deals: 1
SB
North America, California, United States, San Francisco
Shared Deals: 1
Jason Zeng
Asia, Guangdong, China, Shenzhen
Shared Deals: 1
Fadi Ghandour
Asia, United Arab Emirates
Shared Deals: 1
SW
North America, California, United States, San Francisco
Shared Deals: 2

What are some of recent deals done by Legend Star?

Deepin Technology

Haidian, Beijing, China

Deepin Technology focuses on chemistry research using artificial intelligence.

Artificial Intelligence (AI)ChemicalLife Science
SeedMar 19, 2025
Amount Raised: $13,827,051
BlueSky Aviation

Jinan, Shandong, China

BlueSky Aviation focused on the research and development and manufacturing of large-scale extended-range tilt-rotor eVTOL aircraft.

Air TransportationElectric VehicleManufacturing
AngelFeb 27, 2025
Primus Labs

Hong Kong, Hong Kong Island, Hong Kong

Primus connects Web2 data to Web3, offering verified information to AI models while ensuring user privacy.

BlockchainCryptocurrencyWeb3
SeedFeb 20, 2025
Amount Raised: $6,500,000
Ubot Robotics

Shandong, Fujian, China

Ubot Robotics is dedicated to developing leg-and-foot bionic robots.

Machine LearningManufacturingRobotics
Series UnknownSep 11, 2024
CytoTronics

Boston, Massachusetts, United States

CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.

Test and Measurement
SeedSep 5, 2024
Amount Raised: $13,500,000
Pharos

Menlo Park, California, United States

Pharos is a developer of a full-stack parallel blockchain network that connects trustless Web3 developments with current FinTech services.

BlockchainCryptocurrencyFinTech
SeedSep 1, 2024
Amount Raised: $8,000,000
Arnatar Therapeutics

San Diego, California, United States

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

BiopharmaMedical
Series AApr 8, 2024
Amount Raised: $50,000,000
Rgenta Therapeutics

Cambridge, Massachusetts, United States

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

BiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series ANov 29, 2022
Amount Raised: $52,000,000
Merico

San Francisco, California, United States

Merico develops code analytics technology to support engineering teams in understanding and optimizing productivity and code quality.

Developer ToolsInformation TechnologyMachine LearningSaaSSoftware
Series AOct 26, 2021
Amount Raised: $12,389,916
Adlai Nortye

Hangzhou, Zhejiang, China

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

BiotechnologyHealth CareOncologyPharmaceutical
Series DJul 13, 2021
Amount Raised: $100,000,000